PRA7
REGISTERED - SEC. 7 REQUEST ABANDONED
10/09/2025
Back to search
Official data from USPTO
EMPOWER PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EMPOWER PHARMA
ST13
US500000088262059Class
5
Filing
88262059
Registration
7504902
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
51
Latest update
10/10/2025
Trademark type
Word
Nice classes
5
Filing date
01/15/2019
Registration date
09/17/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/17/2024
Last transaction
10/10/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
03/22/2018
First use in commerce
03/22/2018
Drawing code
4
Owner type
16
Owner location
HOUSTON, TX
Examiner
BERTRAND,JOSEPH A
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
EMPOWER CLINIC SERVICES, L.L.C.
Empower Pharma, LLC
Representatives
JOHN A YATES PATTERSON & SHERIDAN LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Sterile prescription pharmaceuticals for human usesterile injectable pharmaceuticalscompounded sterile injectable pharmaceuticalsmedicationsvitaminsmineralssupplementsalpha-lipoic acidascorbic acidbacteriostatic waterbranched-chain amino acidsvitamin Bmixtures of papaverine and phentolaminecalcium gluconatemixtures of gamma-aminobutyric acid and magnesium chloride hexahydrate and taurine and theanineubiquinonecyanocobalamindexpanthenoledetate disodiumurofollitropingrowth hormone releasing peptideshuman chorionic gonadotropinipamoreline acetatel-arginine HCll-carnitinemixtures of methionine and inositol and choline chloride and cyanocobalaminmixtures of methionine and inositol and choline chloride and l-carnitine and thiamine HCl and dexpanthenolmixtures of methionine and inositol and choline chloridel-lysine HClmenotropinsmethylcobalaminnandrolone decanoatephenylephrine HClprogesteronepyridoxine HClmixtures of papaverine and phentolamine mesylate and prostaglandin and atropine sulfatesermoreline acetatesodium bicarbonatetaurinetestosterone cypionatemixtures of testosterone cypionate and testosterone propionatetestosterone enanthatetestosterone propionatemixtures of l-arginine HCL and l-citrulline and l-ornithine HClmixtures of papaverine and phentolamine mesylate and prostaglandin E1
Publications
History of USPTO decisions and trademark events.
51 publications found
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
03/28/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/27/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
10/30/2024
ES7R
TEAS SECTION 7 REQUEST RECEIVED
10/29/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/17/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
09/17/2024
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
08/11/2024
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
04/29/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/02/2024
PUBO
PUBLISHED FOR OPPOSITION
04/02/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/13/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/26/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
02/26/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/26/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
02/26/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/26/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/06/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/06/2024
ALIE
ASSIGNED TO LIE
01/05/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
08/10/2023
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
06/13/2023
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
11/30/2022
DOCK
ASSIGNED TO EXAMINER
10/28/2022
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
04/29/2022
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
10/29/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
04/23/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
10/23/2020
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
04/23/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/19/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/19/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/19/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/19/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/19/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/23/2019
GNSL
LETTER OF SUSPENSION E-MAILED
10/23/2019
CNSL
SUSPENSION LETTER WRITTEN
10/23/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/18/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/16/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/16/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/23/2019
GNRT
NON-FINAL ACTION E-MAILED
08/23/2019
CNRT
NON-FINAL ACTION WRITTEN
08/23/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/02/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/01/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/01/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/03/2019
GNRT
NON-FINAL ACTION E-MAILED
04/03/2019
CNRT
NON-FINAL ACTION WRITTEN
04/03/2019
DOCK
ASSIGNED TO EXAMINER
03/28/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/06/2019
Continuous trademark protection
Get notified about every new filing that threatens EMPOWER PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.